医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Promega Opens New Shanghai Facility

2012年11月15日 AM02:25
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

Promega celebrates the grand opening of a new facility for its China operations that includes molecular biology reagent production, research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market. (Photo: Business Wire)Promega celebrates the grand opening of a new facility for its China operations that includes molecular biology reagent production, research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market. (Photo: Business Wire)

View and Share Photo

Close Window


MADISON, Wis.

Promega Corporation celebrates the opening of a new facility for its China operations. The new site for Shanghai Promega Biological Products, Ltd. both replaces an existing molecular biology reagent production site and it provides additional research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market.

Promega celebrates the grand opening of a new facility for its China operations that includes molecu ...

Promega celebrates the grand opening of a new facility for its China operations that includes molecular biology reagent production, research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market. (Photo: Business Wire)

Since its purchase in June of this year, the building has been equipped for the manufacture of molecular biology and molecular diagnostic reagents. Under the leadership of General Manager Tom Duan, a team of 40 scientists, technicians and administrators will begin operations in the new facility in the next few weeks.

“China is an integral part of Promega’s manufacturing and business operations. In 1985, Promega and two Chinese partners established Sino-American Biotechnology Corporation (SABC), the first China-US biotech joint venture in China,” says Promega CEO Bill Linton. “This recent investment in the new Shanghai cGMP manufacturing facility represents Promega’s continued commitment to life science in China.” Among its 15 global branches, Promega also has a sales and marketing branch in Beijing.

The new facility, called Shanghai Promega Life Science Center, is one of five Promega manufacturing sites worldwide. Together these facilities manufacture biological and chemical reagents and instruments used in both life science research and molecular diagnostics. Promega products are manufactured under certified quality systems that meet the requirement of ISO 9001 or ISO 13485, depending on product intended use.

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20121114006409/en/

CONTACT

Promega Corporation
Penny Patterson, (608) 274-4330
Sr.
Director, Communications
penny.patterson@promega.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Brightree发布面向居家医疗器械的首个患者App
  • Brightreeが初のHME向け患者アプリを発表
  • Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
  • ポットネットワーク・ホールディングスがSEC報告会社登録に基づきPCAOB監査人による完全な監査・レビュー済みの財務報告書を公表
  • Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc